6.72 USD
▼-0.28-4.00%
盘后 6.85 0.00%
2026-11-20
市值
$431.55M
市盈率
—
EPS
-0.47
股息率
—
52 周区间
3.86 – 9.31
成交量
438.98K
Beta
1.34
目标价
15.40
52W 低 3.8652W 高 9.31
价格走势
公司简介
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes. The company was incorporated in 2012 and is headquartered in Newpo...